The value of dose intensification of standard chemotherapy for advanced breast cancer using colony-stimulating factors alone

Cancer Treat Rev. 1998 Jun;24(3):173-84. doi: 10.1016/s0305-7372(98)90048-2.

Authors

M Clemons¹, R Gharif, A Howell

Affiliation

¹ CRC Department of Medical Oncology, Christie Hospital, Manchester, U.K.

PMID: 9767733
DOI: 10.1016/s0305-7372(98)90048-2

No abstract available

Publication types

Review

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
Breast Neoplasms / drug therapy*
Breast Neoplasms / pathology
Chemotherapy, Adjuvant
Disease Progression
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Granulocyte Colony-Stimulating Factor / administration & dosage
Granulocyte Colony-Stimulating Factor / therapeutic use*
Granulocyte-Macrophage Colony-Stimulating Factor / administration & dosage
Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use*
Humans
Neoplasm Staging
Remission Induction
Survival Rate

Substances

Granulocyte Colony-Stimulating Factor
Granulocyte-Macrophage Colony-Stimulating Factor